Exablate Neuro
Commercial- Indications
- Essential Tremor, Parkinson's Disease
Company intelligence / Profile preview
Insightec’s MR-guided Focused Ultrasound technology is commercially approved for several indications including essential tremor, Parkinson’s disease, uterine fibroids, and pain palliation of bone metastases. Clinical trials are ongoing in additional oncology and neurological indications. The company has published pivotal trial data in leading journals such as the New England Journal of Medicine.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Insightec.